---
title: "Shenzhen Capital Group Has Cultivated 300 Listed Companies: Promoting Deep Integration of Capital and Industry"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292248460.md"
description: "ROKAE ROBOTICS, the 300th listed company cultivated by Shenzhen Capital Group (SCGC), was listed on the Hong Kong Stock Exchange on July 9. Its 2025 annual report shows that SCGC has cumulatively invested in over 1,700 companies, with annual decision-making amounts exceeding RMB 10 billion, primarily targeting early-stage and growth-stage projects as well as hard technology sectors such as semiconductors and biopharmaceuticals. The company adheres to the strategy of \"investing early, investing small, holding for long term, and investing in hard technology,\" committed to promoting the deep integration of capital and industry and cultivating new quality productive forces"
datetime: "2026-07-09T22:45:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292248460.md)
  - [en](https://longbridge.com/en/news/292248460.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292248460.md)
---

# Shenzhen Capital Group Has Cultivated 300 Listed Companies: Promoting Deep Integration of Capital and Industry

On July 9, ROKAE ROBOTICS, a portfolio company of Shenzhen Capital Group (SCGC), was listed on the main board of the Hong Kong Stock Exchange, surging 15.21% at the close of the day. It is reported that this is the 300th listed company cultivated by SCGC. According to the 2025 annual report recently released by SCGC, as of the end of 2025, the firm had cumulatively invested in more than 1,700 companies over the past two decades. In 2025, the total amount of projects approved by the company exceeded RMB 10 billion, with over 90% allocated to early-stage and growth-stage projects.

Looking back at its investment path in 2025, although the annual report did not disclose specific details, data from various sources indicate that the invested projects covered popular market sectors such as semiconductors, biopharmaceuticals, new materials, and embodied AI. SCGC stated that in 2025, the company consistently adhered to the investment strategy of "investing early, investing small, holding for long term, and investing in hard technology." In 2026, it will continue to contribute greater strength to the cultivation and development of new quality productive forces. Promoting the deep integration of capital and industry may be the inevitable path for the venture capital industry to achieve high-quality development. (China Securities Journal)

### Related Stocks

- [03752.HK](https://longbridge.com/en/quote/03752.HK.md)

## Related News & Research

- [Rokae Robotics files HKEX next-day disclosure return, raises share capital by 3,454,700 shares](https://longbridge.com/en/news/295459259.md)
- [Momentum sees EM equity gains increasingly concentrated as top 10 nears 40% of index](https://longbridge.com/en/news/296076259.md)
- [Alphamab Oncology says China NMPA accepts Anbenitamab NDA for first-line HER2+ advanced breast cancer](https://longbridge.com/en/news/296209703.md)
- [Aikobio’s AK0406 flu prevention drug wins China IND clearance for clinical trials](https://longbridge.com/en/news/296204995.md)
- [JLR’s new Freelander 8 takes off with 10,000 orders in first 48 hours](https://longbridge.com/en/news/296029046.md)